Leukemia
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
September, 2024
September 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
« Aug
Leukemia
Sep 10, 2024, 02:28 |
Blog
Supriya Peshin: Honored to meet Dr. Guillermo Garcia-Manero
Supriya Peshin, Internal Medicine Resident, Ballad Health shared a post on X: "What an honor…
Sep 10, 2024, 00:28 |
Blog
Chloe’s leukemia battle: ‘My knees just gave way’ - Children’s Cancer Institute
Children’s Cancer Institute shared the following on LinkedIn: “Chloe was a happy 9-year-old who loved…
Sep 9, 2024, 13:41 |
Dialogues
Dr. Vivek Subbiah on Pioneering Precision Oncology and Global Clinical Trials | OncoInfluencers #13
Dr. Vivek Subbiah, Chief of Early Phase Drug Development at Sarah Cannon Research Institute, joins…
Sep 5, 2024, 15:20 |
Dialogues
Global Access and Equity in Cancer Care: Pat Garcia Gonzalez v1 | United Against Cancer
Join us for this episode of United Against Cancer, where Dr. Pat Garcia-Gonzalez, CEO of…
Aug 27, 2024, 21:35 |
Blog
Tinatin Muradashvili: The role of metabolic comorbidities and viral infections in monoclonal gammopathy
Tinatin Muradashvili, Hematology and Oncology Fellow at Emory University, shared a post on X about…
Aug 23, 2024, 13:00 |
Blog
OncoInfluencers to Follow on Social Media: Dr. Natalia Baran
We are excited to introduce Dr. Natalia Baran, a leading expert in leukemia research, as…
Aug 20, 2024, 14:29 |
Blog
Rahul Banerjee: What's the best unifying term for the equivalent of bridging therapy but before apheresis?
Rahul Banerjee shared a poll on X: "Maybe more of a CAR-T consensus here than…
Aug 18, 2024, 13:57 |
Blog
Oncoinfluencers to Follow on Social Media: Dr. Katy Rezvani
We are excited to spotlight Dr. Katy Rezvani, a prominent figure in the oncology community,…
Aug 14, 2024, 07:20 |
Drugs
Keith W Pratz: Novel risk signature for AML treated with Azacitidine and Venetoclax
Keith W Pratz, Director of Leukemia at the Hospital of University of Pennsylvania, shared on…
Aug 13, 2024, 13:50 |
Insight
Fieke Hoff: The need for a refined risk stratification model for older patients with AML
Fieke Hoff, Clinical hematology/oncology fellow at NIH NHLBI, shared on X: "Excited to share our…
Aug 12, 2024, 13:32 |
Insight
Erman Akkus: Which cancers are most frequently diagnosed in males aged 15-34 worldwide?
Erman Akkus, Medical Oncologist at Ankara University, shared on X: "Which cancers are most frequently…
Aug 8, 2024, 10:47 |
Blog
Seattle Children's named their newest research building, Building Cure, in honor of B. Wayne Hughes
Seattle Children's posted on LinkdedIn: "Today, we named our newest research building, Building Cure, in…
Aug 5, 2024, 05:34 |
Dialogues
Unlocking the Immune System: Dr. Levisetti on Cue Biopharma's New Biologics
Matteo Levisetti, M.D is chief medical officer of CUE Biopharma which is a clinical-stage biopharmaceutical…
Aug 1, 2024, 04:27 |
Blog
The Leukemia and Lymphoma Society: "I wanted to be that light for other teenagers" - Georgia
The Leukemia and Lymphoma Society shared on X: " 'I wanted to be that light…
Jul 31, 2024, 11:52 |
Insight
Ajay Major: PFS benefit in AMPLIFY Phase III trial in CLL
Ajay Major, Lymphoma Faculty at the CU School of Medicine, shared on X: "Press release…
Jul 30, 2024, 13:25 |
Insight
David Fajgenbaum: Untold story of a drug initially approved for Castleman Disease that saved a young girl's life
David Fajgenbaum shared on X: "Did you know that a repurposed drug saved the most…
Jul 30, 2024, 13:23 |
Insight
Treatment of CML in pregnant patients and patients who are breastfeeding
FDA Oncology shared on X: An expert panel convened by FDA provides perspectives on drug…
Jul 30, 2024, 07:14 |
Blog
Naveen Pemmaraju: Superb clinic and research teams working together in Team Pemm clinic
Naveen Pemmaraju shared a post on X: "Superb clinic and research teams working together in…
Jul 29, 2024, 02:07 |
Blog
Riccardo Braglia's cancer survivorship story - Conquer Cancer
Conquer Cancer shared on LinkedIn: "Riccardo Braglia has been personally affected by cancer three times…
Jul 28, 2024, 15:35 |
Societies
Uma Borate: Celebrating the hard work of the hematology community with a Bollywood theme at ASH24
Uma Borate, Acute Leukemia Clinical Section Head and Research Director at James Cancer Hospital shared…
Jul 26, 2024, 13:51 |
Blog
Oncoinfluencers to Follow on Social Media: Dr. Naveen Pemmaraju
We are excited to feature Dr. Naveen Pemmaraju, a prominent expert in the field of…
Jul 25, 2024, 13:59 |
Blog
Oncoinfluencers to Follow on Social Media: Dr. Hagop Kantarjian
We are excited to feature Dr. Hagop Kantarjian, a distinguished figure in Hematology/Oncology, as our…
Jul 22, 2024, 14:33 |
Career
Sharon Castellino has been appointed to the board of directors of The Leukemia and Lymphoma Society - Winship Cancer Institute
Winship Cancer Institute of Emory University shared a post on LinkedIn: "Winship pediatric hematologist Sharon…
Jul 15, 2024, 02:18 |
Blog
Antonio Ocejo: First week of hematology/oncology fellowship at MSKCC
Antonio Ocejo, Hematology and Oncology Fellow at Memorial Sloan Kettering Cancer Center, on X: "First week of…
Jul 13, 2024, 19:41 |
Insight
Joshua Zeidner: Subset analyses from QUAZAR study
Joshua Zeidner, Associate Professor at UNC Lineberger, shared on X about a recent paper by…
Jul 13, 2024, 09:41 |
Insight
IMMONC - Immune Oncology Research Institute's Experience in Advancing Clinical Cancer Research in Armenia
Cancer affects people across the world regardless of their socioeconomic status. However, low- and middle-income…
Jul 12, 2024, 21:26 |
Blog
Roberto Casalaz: Role of rehabilitation for children and adolescents with cancer
AIEOP shared Roberto Casalaz, Pediatric Physiotherapist at IRCCS Burlo Garofolo, on LinkedIn: "Great work by authors…
Jul 10, 2024, 08:52 |
Blog
Nitin Jain: CML response definitions
Fadi Haddad, Assistant Professor at the Leukemia Department at the MD Anderson Cancer Center, reposted…
Jul 9, 2024, 13:43 |
Blog
Oncoinfluencers to Follow on Social Media: Dr. Talha Badar
At OncoDaily, we are excited to feature Dr. Talha Badar, a leading hematologist/oncologist, as our…
Jul 8, 2024, 09:03 |
Career
Livius Penter: Consider Applying for Scientific Researcher In My Lab!
Livius Penter, Max-Eder Research Group Leader at Hematology/Oncology Charité - University Medicine Berlin, made the…
Jul 6, 2024, 08:53 |
Career
S K Gupta: I’ve completed my Fellowship in Leukemia/BMT/CAR T-Cell at The University of British Columbia
S K Gupta, Oncologist at Medanta, shared on LinkedIn: "I’m happy to share that I’ve…
Jul 5, 2024, 05:17 |
Blog
Carmen Uscatu: How we can create centers of excellence
Carmen Uscatu, Founding Member and President at Give Life, shared on LinkedIn: "“There is no…
Jul 4, 2024, 08:25 |
Blog
Lilit Grigoryan: Do you know why she is crying? She’s overcome pediatric cancer
Lilit Grigoryan, Fundraising and Donor Relations Manager at City of Smile Charitable Foundation, shared on…
Jul 3, 2024, 00:19 |
Blog
Jame Abraham: Cornerstone of patient safety and quality is our nursing team
Jame Abraham shared on X: "Leukemia is one of the toughest diagnoses. Truly appreciate inpatient team…
Jul 2, 2024, 23:10 |
Blog
Shahrin Ahmed: Pregnancy complications are more likely for young cervical cancer and leukemia survivors
Shahrin Ahmed, Medical Specialist at the Canadian Cancer Society, shared on X: "Pregnancy complications are more…
Jun 28, 2024, 16:07 |
Blog
Andre M.N. Renzaho: A great event for African-Australians on cancer awareness
Andre M.N. Renzaho, Distinguished Professor and Professor of Humanitarian and Development Studies, School of Medicine…
Jun 26, 2024, 05:00 |
Blog
Lachelle Dawn: Fellows can join the Dana Farber’s division of Leukemia
Lachelle Dawn, Hematologist and Scientist at Dana-Farber Cancer Institute, shared on X: “I work with…
Jun 25, 2024, 06:17 |
Blog
Atrium Health Foundation's special guests who are helping to kick off the Keep Pounding 5K
Atrium Health Foundation shared on LinkedIn: "Meet our special guests, Travis and Cameron, who are…
Jun 23, 2024, 21:14 |
Blog
Raul Cordoba: How to make impact on hematology?
Raul Cordoba shared on X: "How to make impact on hematology? Discover it by joining…
Jun 20, 2024, 09:56 |
Blog
360° Model to address leukemia by Vuela Fundación
Childhood Cancer International shared on LinkedIn: "Vuela Fundación is a foundation originated in Mexico with…
Jun 19, 2024, 23:09 |
Blog
Wei Ying Jen: Very grateful to be standing on the shoulders of giants
Wei Ying Jen, Haematologist and Leukemia Doctor at MD Anderson Cancer Center, shared on X:…
Jun 19, 2024, 21:45 |
Insight
Fadi Haddad: Phase 1/2 trial of DSP-5336 menin inhibitor by Naval Daver
Fadi Haddad, Assistant Professor, Leukemia Department at MD Anderson Cancer Center, shared a post on X/Twitter:…
Jun 19, 2024, 12:19 |
Blog
Oncology Advance - See this month’s highlights from the ESMO portfolio
Oncology Advance shared a post on X: "See this month’s highlights from the ESMO portfolio. Featured…
Jun 19, 2024, 01:26 |
Blog
Ami Patel: An honor to work with Naveen Pemmaraju on MPN review article
Ami Patel, Hematologist at Huntsman Cancer Institute, shared a post by Naveen Pemmaraju on X, adding: “An…
Jun 18, 2024, 17:31 |
Insight
Amer Zeidan: Nothing is better than training international students on research
Amer Zeidan shared a post on X: “Nothing better training international students on research. True pleasure…
Jun 18, 2024, 10:27 |
Insight
Naveen Pemmaraju: Our brand new MPN state-of-the-art review paper
Naveen Pemmaraju shared on LinkedIn: . "Super excited to share our brand…
Jun 17, 2024, 07:13 |
Blog
Joshua Omale: Celebrating 20 Years of Lifesaving Generosity
Joshua Omale shared on LinkedIn: "Celebrating 20 Years of Lifesaving Generosity: Thank You, Blood Donors. Today,…
Jun 16, 2024, 14:05 |
Blog
Farina Arreguin: Germline predisposition of genetic testing in myeloid malignancies
Farina Arreguin, a Pediatric Oncologist at Star Medical Private Children’s Hospital, shared a post on…
Jun 11, 2024, 12:10 |
Blog
Michelle Kirschner: Sami Mansfield will speak about Exercise Oncology for the Cancer Survivorship Provider Network
Michelle Kirschner recently shared a post by Sami Mansfield, Founder of Cancer Wellness for Life,…
Jun 9, 2024, 07:57 |
Positive
Lucia Masarova: The best leukemia ladies group in the world
Lucia Masarova, Assistant Professor at MD Anderson Cancer Centre, shared a post by Wei Ying…
May 31, 2024, 05:37 |
Societies
A groundbreaking moment from 2017— the FDA approval of Kymriah - St. Baldrick's Foundation
St. Baldrick's Foundation shared a post on LinkedIn: “Today, we're looking back on a groundbreaking…
May 24, 2024, 13:11 |
Blog
Kelley Wood: We observed significant improvements in Quality of Life across 12 different cancer types
Kelley Wood, Research Director at ReVital Cancer Rehab, made the following post on LinkedIn: “NEW PUB…
May 23, 2024, 09:19 |
Blog
Stephen D. Nimer's recent study could lead to a new combination therapy for leukemia
Sylvester Comprehensive Cancer Center shared a post on X: “Stephen D. Nimer's recent study could lead…
May 22, 2024, 01:53 |
Insight
Nitin Jain: Looking forward to presenting phase 2 trial of frontline treatment for patients with CLL at EHA 2024
Nitin Jain, Professor of the Department of Leukemia at MD Anderson Cancer Center, shared on…
May 18, 2024, 04:46 |
Blog
Douglas Flora: Wonderful start to the day at The Leukemia and amp; Lymphoma Society’s Light The Night executive breakfast
Quoting Douglas Flora’s post on LinkedIn: “Had a wonderful start to the day at The Leukemia…
May 15, 2024, 14:47 |
Drugs
Hagop Kantarjian: New research is expanding inotuzumab use into frontline, for MRD+, and in combination with blinatumomab
Nicholas Short, Associate Professor at the Department of Leukemia at MD Anderson Cancer Center, shared…
May 13, 2024, 13:11 |
Insight
Justin Kaner: To transplant or not to transplant…..
Justin Kaner, Assistant Professor of the Leukemia Program at Weill Cornell, shared on X: "To…
May 10, 2024, 11:47 |
Blog
Andrew M. Evens: Thank you for the invite to the 1st HemeOnc Pulse LIVE
Andrew M. Evens, Deputy Director for Clinical Services at Rutgers Cancer Institute, recently shared on…
May 5, 2024, 06:00 |
Cancer Types
Acute Lymphoblastic Leukemia in Adults: What patients should know about
What is Acute Lymphoblastic Leukemia? Acute lymphoblastic leukemia (ALL) is a type of cancer that…
Apr 30, 2024, 16:14 |
Stories
Pat Garcia-Gonzalez: Ethiopia Revisited - on the strength of the human spirit and progress in the face of adversity
Pat Garcia-Gonzalez, Chief Executive Officer at The Max Foundation, shared on LinkedIn: "Earlier last week,…
Apr 28, 2024, 13:08 |
Blog
Celebrating 5-year anniversary of being cancer-free Jennifer’s daughter, Inara - Canadian Cancer Society
Canadian Cancer Society shared a post on LinkedIn: “In the winter of 2016, Jennifer’s daughter,…
Apr 25, 2024, 20:01 |
Blog
Naveen Pemmaraju: Serious meeting of the heme minds today with Prof. Naveen Pemmaraju and Prof. Jason Westin
Naveen Pemmaraju shared on X: "Co-fellows to Co-Professors together at MD Anderson Cancer Center! Serious…
Apr 21, 2024, 09:04 |
Blog
Naveen Pemmaraju: Brilliant talk Leukemia Wed noon Grand Rounds by Dr. Sanam Loghavi on new applications of Optical Genome Mapping (OGM) in AML!
Naveen Pemmaraju posted on X/Twitter: "Brilliant talk today MD Anderson Cancer Center Leukemia Wed noon…
Apr 20, 2024, 18:21 |
Insight
Piotr Wysocki: Pregnancy and anticancer immunotherapy - How safe is accidental exposure to immune checkpoint inhibitors?
Piotr Wysocki, Professor of Medicine and Head of the Department of Oncology at Jagiellonian University…
Apr 15, 2024, 02:40 |
Insight
Naveen Pemmaraju: Check out our exciting growing international BPDCN collaboration with Dr. Gevorg Tamamyan and Armenia
Quoting Naveen Pemmaraju on X/Twitter: "Check out our exciting growing international BPDCN collaboration with Dr.…
Apr 9, 2024, 05:27 |
Positive
George Yaghmour: Against the relentless battle of leukemia, success demands unwavering strength
George Yaghmour, Associate Director of USC Norris Blood and Marrow Transplant Program at University of Southern…
Apr 8, 2024, 21:58 |
Blog
,
Insight
Katherine Masih: Super interesting work on activation of CAR-negative T-cells and subsequent cytotoxic killing of leukemia
Katherine Masih, Medical Student at University of Miami Miller School of Medicine, shared on X/Twitter:…
Apr 6, 2024, 12:48 |
Positive
Naveen Pemmaraju: MD Anderson Cancer Center (MDACC) is a special place of hope and inspiration
Quoting Naveen Pemmaraju's post on LinkedIn: "When On Service: I am an Attending in the…
Apr 5, 2024, 16:47 |
Positive
Naveen Pemmaraju: Awesome team to round with on Leukemia Inpatient wards this month
Naveen Pemmaraju recently posted on X: "Awesome team to round with on Leukemia Inpatient wards…
Mar 12, 2024, 15:53 |
Blog
Naveen Pemmaraju: Congratulations to Kuo-Kai Chin for being awarded the Ruben Mesa Junior Clinical Investigator Award
Naveen Pemmaraju posted on X/Twitter: ''Congratulations to Kuo-Kai Chin for being awarded the Ruben Mesa…
Mar 9, 2024, 12:53 |
Blog
Amer Zeidan: No leukemia cell would stand a chance against this group
Amer Zeidan recently posted on X/Twitter: "No leukemia cell would stand a chance against this group."…
Mar 2, 2024, 19:00 |
Opinion
Richard Shadyac: How many of us can say without a doubt, “I know why I was born.”?
Shannon Goldberg-Cruz, Head of Entertainment and Influence at St. Jude Children's Research Hospital, shared a…
Feb 21, 2024, 20:45 |
Blog
Peter Pisters: Delighted to drop by MD Anderson Cancer Center's Leukemia faculty to discuss the exceptional breakthroughs over the years
Peter Pisters, President at MD Anderson Cancer Center, shared on LinkedIn: “Delighted to drop by…
Jan 25, 2024, 13:45 |
Blog
Satya Prakash Yadav: Bone marrow transplant is life-changing event for children
Satya Prakash Yadav, Paediatric Hemato Oncology and Bone Marrow Transplant Specialist at Medanta The Medicity,…
Jan 23, 2024, 18:10 |
Insight
Manasi Gupta: What an exceptional learning experience!
Prashant Mehta, Joint Editor of Indian Journal of Medical and Paediatric Oncology, shared an X…
Jan 10, 2024, 12:42 |
Blog
Danielle Hammond: Proof of concept and breaks the yoke of the infusion center
Danielle Hammond, Assistant Professor at the Department of Leukemia at MD Anderson Cancer Center, shared…
Jan 9, 2024, 13:10 |
Blog
Hagop Kantarjian: Updates on the management of Ph-positive ALL
Hagop Kantarjian, Chair of MD Anderson Cancer Center, shared on X/Twitter: “Updates on the management…
Dec 23, 2023, 17:05 |
Blog
Hagop Kantarjian: Traditional Medicare or Medicare Advantage?
Hagop Kantarjian, Chair of MD Anderson Cancer Center, shared on X/Twitter: "Traditional Medicare or Medicare…
Dec 18, 2023, 21:10 |
Career
Congratulations to Dr. Ross Levine who was honored by the The Leukemia and Lymphoma Society - Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center shared on LinkedIn: "Congratulations to leukemia specialist and physician-scientist Dr.…
Dec 16, 2023, 16:32 |
Blog
Keith Pratz: Mentors can influence greatly your career
Keith Pratz, Associate Professor of Medicine (Hematology-Oncology) at the Hospital of the University of Pennsylvania,…
Dec 11, 2023, 11:01 |
Stories
Danielle Carnival: You’re never too young to make a difference!
Danielle Carnival, Deputy Assistant to President Biden for the Cancer Moonshot, posted on X/Twitter: "The…
Dec 2, 2023, 17:33 |
Career
Leukaemia and Myeloma Research UK awarded grants to Neil Rodrigues and Concetta Bubici
Leukaemia and Myeloma Research UK shared on X (Twitter): "We’re pleased to have awarded £57,500…
Nov 28, 2023, 22:45 |
Blog
Doug R. Lowy: Good news from CDC Cancer
Doug R. Lowy, Acting Director of National Cancer Institute, made the following post on Twitter: "Good news…
Nov 22, 2023, 02:47 |
Blog
Lucia Masarova: Let's tackle the inflammation in myelofibrosis! Era of combinational therapies is here
Lucia Masarova, Assistant Professor of the Department of Leukemia at MD Anderson Cancer Center, shared…
Nov 3, 2023, 12:29 |
Insight
Talha Badar: In view of recent approval of IDH1i in MDS brief tweetorial
Talha Badar, Assistant Professor of Oncology at Mayo Clinic Comprehensive Cancer Center, posted on X/Twitter:…
Oct 27, 2023, 17:01 |
Drugs
Revumenib in relapsed or refractory KMT2Ar acute leukemia - Syndax Pharmaceuticals
Nicole McNeer, Senior Medical Director and Clinical Leader at Syndax Pharmaceuticals, shared a post by…
Oct 18, 2023, 21:48 |
Blog
Yasmine Yasser: Excited to share that my thesis defense at the National Cancer Institute was a success!
Yasmine Yasser, Medical Oncology and Hematology Assistant Lecturer at the National Cancer Institute, Cairo University,…
Oct 1, 2023, 16:29 |
Blog
Tracey O'Brien: At the Cancer Institute New South Wales (NSW), we’re proud to support incredible New South Wales researchers like Nunki Hassan.
Tracey O'Brien, New South Wales Chief Cancer Officer, shared a post by Cancer Institute New…
Sep 22, 2023, 11:56 |
Positive
Dean Crowe: Grateful for these two!
Quoting Dean Crowe, Founder and CEO of Rally Foundation for Childhood Cancer Research, on LinkedIn:…
Sep 14, 2023, 17:52 |
Career
Naveen Pemmaraju: Deeply honored to share that I have been Promoted to Professor of Leukemia!
Naveen Pemmaraju recently shared on X/Twitter: "Deeply honored to share that I have been Promoted…
Aug 31, 2023, 18:44 |
Blog
Anand Patel: It was a pleasure speaking about accelerated/blast-phase MPNs at the Video Journal of Hematological Oncology IWAL meeting
Quoting Anand Patel, an Assistant Professor and the Director of Inpatient Leukemia Service at the…
Aug 31, 2023, 18:42 |
Blog
Piers Blombery: Well done to Martin Vu for publishing this important health economic analysis on the cost-effectiveness of TP53/IGHV molecular testing in chronic lymphocytic leukemia in Australia.
Aug 20, 2023, 18:39 |
Blog
Naveen Pemmaraju: Delighted to spend a few moments with Nobel Laureate Dr. Jim Allison at our Faculty Awards ceremony.
Quoting Naveen Pemmaraju, Assistant Professor in the Department of Leukemia at Anderson Cancer Center, stated…
Aug 20, 2023, 16:32 |
Blog
Hagop Kantarjian: Join us in welcoming Alexandre Bazinet, MDCM, MSc to our MD Anderson Cancer Center Leukemia Faculty!
Hagop Kantarjian, Leukemia Professor and Chair at MD Anderson Cancer Center, shared on Twitter: "Join…
Aug 17, 2023, 16:33 |
Blog
Amer Zeidan: It has been 16 years and 300 papers since my first paper was published in July 2007.
Amer Zeidan wrote in a recent tweet: ''It has been 16 years and 300 papers…
Aug 15, 2023, 08:33 |
Positive
This is a story of resilience. Today, he stands as a symbol of hope - St. Baldrick's Foundation
Quoting from St. Baldrick's Foundation's LinkedIn: "This is a story of resilience. Shortly after a…
Aug 8, 2023, 18:54 |
Blog
We have been able to bring novel state-of-the-art clinical trials to patients in the Tampa Bay region and beyond, many of which would not have access to trials otherwise - David Swoboda
Aug 5, 2023, 18:18 |
Blog
MENA NCCN 2022-2023 guidelines have been published and posted on the NCCN website and the MNGHA website - Kanan Alshammari
We are happy to announce that the MENA NCCN 2022-2023 guidelines have been published and…
Aug 4, 2023, 16:16 |
Positive
Every patient deserves access to quality cancer care - Gwen Nichols
Every patient deserves access to quality cancer care. Yet some groups of patients face more…
Jul 22, 2023, 17:56 |
Drugs
High response rates in poor-risk population - Hagop Kantarjian
Our study of aza + ven + pevonedistat NEDD8-activating enzyme inhibitor in secondary AML &…
1
2
All:
118
Posts:
1 - 100
OncoDaily Announces Strategic Partnership with the Asian Fund for Cancer Research Limited (AFCR)
Peyo the Therapy Horse: Comforting Terminally Ill Patients Through Horse Therapy.
100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2024: Part 3
Small Bowel Cancer: Symptoms & Causes, Types, Diagnosis and Treatment
Mikkael A. Sekeres, Candidate for Secretary of ASH
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube